Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A real-world trial of ILUVIEN® (fluocinolone acetonide) in patients with chronic diabetic macular edema (DME)

Next Previous
Trial Profile

A real-world trial of ILUVIEN® (fluocinolone acetonide) in patients with chronic diabetic macular edema (DME)

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 21 Sep 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fluocinolone acetonide (Primary)
  • Indications Diabetic macular oedema
  • Focus Therapeutic Use
  • Acronyms RETRO-IDEAL

    • Most Recent Events

    • 13 Sep 2018 According to an Alimera Sciences media release, data from this study will be presented at the 2018 Annual Meeting of the Retina Society (Sep 2018).
    • 08 Sep 2017 New trial record
    • 05 Sep 2017 According to an Alimera Sciences media release, results from this trial will be presented during the 17th European Society of Retina Specialists Congress (EURETINA) 2017.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top